Year All20242023202220212020201920182017201620152014 The Chairman of ABIVAX accompanies French President François Hollande during his trip to Cuba on May 11 May 11, 2015 Read More Mechanism of action of ABIVAX’s First-in-class anti-HIV drug published today in peer-reviewed journal Retrovirology April 13, 2015 Read More ABIVAX Recruits First Patient in a Pivotal Phase IIb/III clinical trial with ABX203, a novel immunotherapy against chronic hepatitis B February 26, 2015 Read More TREATMENT OF THE FIRST HIV POSITIVE PATIENT IN ABIVAX’S PHASE IIA CLINICAL TRIAL WITH ABX464 February 02, 2015 Read More ABIVAX, A PRIVILEGED PARTNER OF THE CUBAN LIFE SCIENCE INDUSTRY, WELCOMES INITIATIVE TO RENEW RELATIONS BETWEEN THE USA AND CUBA December 19, 2014 Read More ABIVAX SUCCESSFULLY COMPLETES FIRST-IN-MAN STUDY OF ABX464, A HIGHLY DIFFERENTIATED SMALL MOLECULE TARGETING HIV December 01, 2014 Read More ABIVAX SIGNS AGREEMENT WITH THE FINLAY INSTITUTE November 12, 2014 Read More ABIVAX STRENGTHENS EXECUTIVE MANAGEMENT TEAM WITH SENIOR APPOINTMENTS October 30, 2014 Read More ABIVAX TO PARTICIPATE AT THE WORLD VACCINE CONGRESS October 03, 2014 Read More FRANCECELLVAX CONSORTIUM IS SELECTED FOR ITS PROJECT BY THE “34 PLANS OF THE NEW INDUSTRIAL FRANCE” STEERING COMITEE July 22, 2014 Read More
The Chairman of ABIVAX accompanies French President François Hollande during his trip to Cuba on May 11 May 11, 2015 Read More
Mechanism of action of ABIVAX’s First-in-class anti-HIV drug published today in peer-reviewed journal Retrovirology April 13, 2015 Read More
ABIVAX Recruits First Patient in a Pivotal Phase IIb/III clinical trial with ABX203, a novel immunotherapy against chronic hepatitis B February 26, 2015 Read More
TREATMENT OF THE FIRST HIV POSITIVE PATIENT IN ABIVAX’S PHASE IIA CLINICAL TRIAL WITH ABX464 February 02, 2015 Read More
ABIVAX, A PRIVILEGED PARTNER OF THE CUBAN LIFE SCIENCE INDUSTRY, WELCOMES INITIATIVE TO RENEW RELATIONS BETWEEN THE USA AND CUBA December 19, 2014 Read More
ABIVAX SUCCESSFULLY COMPLETES FIRST-IN-MAN STUDY OF ABX464, A HIGHLY DIFFERENTIATED SMALL MOLECULE TARGETING HIV December 01, 2014 Read More
FRANCECELLVAX CONSORTIUM IS SELECTED FOR ITS PROJECT BY THE “34 PLANS OF THE NEW INDUSTRIAL FRANCE” STEERING COMITEE July 22, 2014 Read More
